ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,862Medicare Part D Prescriptions Filled, Including Refills

Rank: 421 out of 780

$616K Total Retail Price of All Prescriptions

Rank: 213 out of 780

394 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 394 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 5,175 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$90 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 309 175 S3 1 1
SIMVASTATIN 307 271 2 2
AMLODIPINE BESYLATE 221 177 3 4
METFORMIN HCL 221 179 3 8
FUROSEMIDE 173 122 5 7
OMEPRAZOLE 147 111 6 3
LISINOPRIL 137 89 7 6
LOSARTAN POTASSIUM 132 98 8 18
ATORVASTATIN CALCIUM 129 86 9 12
GABAPENTIN 123 81 10 13
PRAVASTATIN SODIUM 122 106 11 9
LEVOTHYROXINE SODIUM 121 106 12 5
HYDROCHLOROTHIAZIDE 118 78 13 10
METOPROLOL TARTRATE 104 78 14 19
CARVEDILOL 103 76 15 14
TAMSULOSIN HCL 99 93 16 36
GLIMEPIRIDE 96 85 17 30
LEVEMIR FLEXPEN 88 55 18 211
NAPROXEN 87 72 19 100
PEN NEEDLE 86 51 20 136
LOSARTAN-HYDROCHLOROTHIAZIDE 85 78 21 33
NOVOLOG FLEXPEN 85 63 21 281
HUMALOG 85 31 21 192
CLOPIDOGREL 78 62 24 34
POTASSIUM CHLORIDE 77 56 25 11
AMLODIPINE BESYLATE-BENAZEPRIL 77 75 25 50
LANTUS SOLOSTAR 71 22 27 121
NOVOLOG 70 36 28 158
CLONIDINE HCL 68 32 29 28
CRESTOR 64 56 30 32
ZOLPIDEM TARTRATE 64 41 30 17
LANTUS 62 36 32 71
MELOXICAM 59 51 33 16
WARFARIN SODIUM 59 48 33 24
INSULIN SYRINGE 57 32 35 80
TRAMADOL HCL 56 12 36 15
NEXIUM 55 55 37 22
METOPROLOL SUCCINATE 54 43 38 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 37 38 26
PLAVIX 53 48 40 45
GLIPIZIDE 53 45 40 74
SYNTHROID 52 52 42 77
ATENOLOL 50 40 43 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.